24 Results for "

β-catenin peptide

" in MedChemExpress (MCE) Product Catalog:
Products (24)

24 Results for "β-catenin peptide" in MCE Product Catalog:

Cat. No.: HY-P1589
CAS No.: 265669-37-2
Target:  

β-catenin

Research Areas:  

Cancer

β-catenin peptide is a 8-aa peptide, and can promote thymocyte positive selection.
loading...
    loading...
7
7 Publications Verification
Cat. No.: HY-P1416
CAS No.: 881188-51-8
Target:  

Wnt

Research Areas:  

Cancer

Foxy-5, a WNT5A agonist, is a mimicking peptide of WNT5A which is a non-canonical member of the Wnt family. Foxy-5 triggers cytosolic free calcium signaling without affecting β-catenin activation and it impairs the migration and invasion of epithelial cancer cells. Foxy-5 effectively reduces the metastatic spread of WNT5A-low prostate cancer cells in an orthotopic mouse model .
loading...
    loading...
7
7 Publications Verification
Cat. No.: HY-P1416A
Target:  

Wnt

Research Areas:  

Cancer

Foxy-5 TFA, a WNT5A agonist, is a mimicking peptide of WNT5A which is a non-canonical member of the Wnt family. Foxy-5 TFA triggers cytosolic free calcium signaling without affecting β-catenin activation and it impairs the migration and invasion of epithelial cancer cells. Foxy-5 TFA effectively reduces the metastatic spread of WNT5A-low prostate cancer cells in an orthotopic mouse model .
loading...
    loading...
3
3 Cited Publications
Cat. No.: HY-P1454
CAS No.: 2247635-23-8
Synonyms: Ac-LPSDDLEFWCHVMY-NH2
Target:  

Wnt

Research Areas:  

Cancer

Fz7-21 (Ac-LPSDDLEFWCHVMY-NH2) is a potent peptide antagonist of FZD7 receptors , selectively binds to FZD7 CRD subclass and alters the conformation of the CRD and the architecture of its lipid-binding groove. The EC50 values are 58 and 34 nM for human and mouse FZD7 CRD, respectively. Fz7-21 impairs the function of FZD7 in Wnt–β-catenin signalling and stem cell function in intestinal organoids .
loading...
    loading...
3
3 Cited Publications
Cat. No.: HY-P1454A
Synonyms: Ac-LPSDDLEFWCHVMY-NH2 TFA
Target:  

Wnt

Research Areas:  

Cancer

Fz7-21 (Ac-LPSDDLEFWCHVMY-NH2) TFA is a potent peptide antagonist of FZD7 receptors , selectively binds to FZD7 CRD subclass and alters the conformation of the CRD and the architecture of its lipid-binding groove. The EC50 values are 58 and 34 nM for human and mouse FZD7 CRD, respectively. Fz7-21 TFA impairs the function of FZD7 in Wnt-β-catenin signalling and stem cell function in intestinal organoids .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-113283
CAS No.: 451-13-8
Purity:  99.46%
Homogentisic acid is an orally active, blood-brain barrier-permeable amyloidogenic compound that functions as both an amyloid component and a pigment precursor. Accumulation of homogentisic acid downregulates tight junction proteins (such as claudin-5, occludin, ZO-1) and impairs blood-brain barrier integrity. Homogentisic acid and its oxidation product benzoquinone acetic acid not only induce the aggregation and fibrosis of multiple proteins (such as 1-42, α-synuclein, SAA, Transthyretin (TTR), atrial natriuretic peptide), but also trigger oxidative stress, damage to the Wnt/β-catenin pathway, and neurotoxicity, leading to ochronosis pigment deposition and synaptic dysfunction. At specific concentrations, homogentisic acid exerts no cytotoxicity or genotoxicity on human peripheral blood lymphocytes, and even counteracts the genotoxicity induced by Irinotecan (HY-16562). Homogentisic acid serves as an important tool molecule for investigating the mechanisms of diseases including ochronosis, secondary amyloidosis, Alzheimer's disease, and colorectal cancer .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-141448
CAS No.: 2763260-34-8
Purity:  98.20%
Research Areas:  

Cancer

NRX-2663 is an enhancer of the interaction between β-catenin, and its cognate E3 ligase, SCF β-TrCP. NRX-2663 enhances the binding of β-catenin peptide for β-TrCP with an EC50 of 22.9 μM and a Kd of 54.8 nM .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-P2272A
Target:  

Wnt β-catenin

Research Areas:  

Cancer

NLS-StAx-h TFA is a selective, cell permeable, stapled peptide Wnt signaling inhibitor with an IC50 of 1.4 μM. NLS-StAx-h TFA efficiently inhibits β-catenin-transcription factor interactions. NLS-StAx-h TFA shows anti-proliferation of cancer cells .
loading...
    loading...
Cat. No.: HY-111836
CAS No.: 2763260-39-3
Purity:  99.07%
Research Areas:  

Cancer

NRX-252114 is a potent enhancer of the interaction between β-catenin, and its cognate E3 ligase, SCF β-TrCP. NRX-252114 enhances the binding of pSer33/S37A β-catenin peptide for β-TrCP with an EC50 of 6.5 nM and a Kd of 0.4 nM. NRX-252114 induces mutant β-catenin degradation .
loading...
    loading...
Cat. No.: HY-P10392AF
Target:  

Wnt β-catenin

Research Areas:  

Cancer

fStAx-35R TFA is the hydrocarbon-stapled peptide. fStAx-35R TFA inhibits Wnt/β-catenin signaling pathway by disrupting the β-catenin-TCF interaction. fStAx-35R TFA can be used in cancer research .
loading...
    loading...
Cat. No.: HY-141449
CAS No.: 2763260-36-0
Purity:  99.89%
Research Areas:  

Cancer

NRX-103094 is a Molecular glue and β-catenin/β-TrCP interaction enhancer, with an EC50 of 62 nM for the binding of pSer33/S37A β-catenin peptide to recombinant β-TrCP/Skp1 complex. NRX-103094 shows selectivity for Ser37 phosphorylation-deficient β-catenin, and has no effect on wild-type doubly phosphorylated β-catenin or other β-TrCP substrates. NRX-103094 can be used in research related to colorectal cancer and ovarian endometrioid adenocarcinoma .
loading...
    loading...
Cat. No.: HY-144984
CAS No.: 2763260-30-4
Purity:  99.51%
Research Areas:  

Cancer

NRX-1933 is a molecular glue (molecular glue) that enhances the interaction between β-catenin and β-TrCP. NRX-1933 promotes the ubiquitination and subsequent degradation of mutant β-catenin. NRX-1933 can be applied to tumor research involving aberrant activation of the Wnt/β-catenin signaling pathway .
loading...
    loading...
Cat. No.: HY-P4858
CAS No.: 41475-27-8
Target:  

GSK-3 Wnt

Research Areas:  

Cancer

C-Peptide 1 (rat), a peptide, is aβ-catenin/GSK-3β activator. C-Peptide 1 (rat) can regulate the Wnt/β-catenin signaling pathway. C-Peptide 1 (rat) can be used for the research of cancer .
loading...
    loading...
Cat. No.: HY-141450
CAS No.: 2763260-38-2
Purity:  99.92%
Target:  

β-catenin

Research Areas:  

Cancer

NRX-103095 is an enhancer of the interaction between β-catenin, and its cognate E3 ligase, SCF β-TrCP. NRX-103095 enhances the binding of pSer33/Ser37 β-catenin peptide for β-TrCP with an EC50 of 163 nM .
loading...
    loading...
Cat. No.: HY-P10392B
Target:  

β-catenin Wnt

Research Areas:  

Cancer

aStAx-35R TFA, a stapled peptide, antagonizes nuclear form of β-catenin and inhibits Wnt signaling. aStAx-35R TFA inhibits competitively the binding of β-catenin to TCF4. aStAx-35R TFA selectively induces growth inhibition of Wnt-dependent cancer cells .
loading...
    loading...
Cat. No.: HY-P2272
CAS No.: 2872559-21-0
Target:  

Wnt β-catenin

Research Areas:  

Cancer

NLS-StAx-h is a selective, cell permeable, stapled peptide Wnt signaling inhibitor with an IC50 of 1.4 μM. NLS-StAx-h efficiently inhibits β-catenin-transcription factor interactions. NLS-StAx-h shows anti-proliferation of cancer cells .
loading...
    loading...
Cat. No.: HY-P10392
CAS No.: 1418863-17-8
Target:  

β-catenin Wnt

Research Areas:  

Cancer

aStAx-35R, a stapled peptide, antagonizes nuclear form of β-catenin and inhibits Wnt signaling. aStAx-35R inhibits competitively the binding of β-catenin to TCF4. aStAx-35R selectively induces growth inhibition of Wnt-dependent cancer cells .
loading...
    loading...
Cat. No.: HY-124826
CAS No.: 691005-38-6
Synonyms: NSC 109268
Target:  

β-catenin

Research Areas:  

Cancer

BC21 (NSC 109268) is a β-catenin/Tcf4 inhibitor with an IC50 of 5 μM. BC21 effectively inhibits the binding of β-catenin to Tcf4-derived peptides and suppresses β-catenin/Tcf4-driven reporter gene activity. BC21 can be utilized in cancer research .
loading...
    loading...
Cat. No.: HY-P11346
CAS No.: 1830290-52-2
Target:  

Cadherin

Research Areas:  

Inflammation/Immunology

N-Cadherin mimic peptide is a N-cadherin agonist. N-Cadherin mimic peptide promotes N-cadherin homodimerization via enhancing β-catenin signaling, inducing early chondrogenesis and cartilage matrix production in mesenchymal stem cells (MSCs). N-Cadherin mimic peptide is promising for research of MSC-based cartilage regeneration .
loading...
    loading...
Cat. No.: HY-107528
CAS No.: 251087-38-4
Target:  

β-catenin GSK-3

Research Areas:  

Cancer

FRATtide is a peptide derived from the GSK-3 binding protein that inhibits the phosphorylation of Axin and β-catenin. FRATtide inhibits GSK-3 binding to Axin .
loading...
    loading...